Stay updated on Ribociclib and Trametinib in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Ribociclib and Trametinib in Solid Tumors Clinical Trial page.

Latest updates to the Ribociclib and Trametinib in Solid Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0. No substantive changes to the study page content are evident.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. The update appears to be a backend version change with no visible content changes.SummaryDifference0.0%

- Check46 days agoChange DetectedRevision: v3.4.2 was introduced replacing v3.4.1; no user-facing changes to study details or functionality were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check53 days agoChange DetectedAdded Revision: v3.4.1 and removed the prior funding-status notice (Revision: v3.4.0), indicating a routine site update.SummaryDifference0.4%

- Check68 days agoChange DetectedAdded a glossary display and updated metadata labels, including 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. The previous QC label wording ('Last Update Submitted that met QC Criteria'), 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.2%

- Check75 days agoChange DetectedFooter revision updated from v3.3.3 to v3.3.4; no changes to study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Ribociclib and Trametinib in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ribociclib and Trametinib in Solid Tumors Clinical Trial page.